EVALUATION OF THE COMPARATIVE EFFECTIVENESS OF VARIOUS ANTIBIOTIC PROPHYLAXIS PROTOCOLS IN REDUCING POSTOPERATIVE SURGICAL SITE INFECTIONS IN TYPHOID ILEAL PERFORATION SURGERIES

Main Article Content

Dr Mujeeb Ur Rehman Sahito
Dr Naeem Ul Karim Bhatti
Dr Shahnawaz Abro
Dr Sajjad Hussain Qureshi
Dr. Syed Kashif Ali Shah
Dr Shahida Baloch
Dr Navin Kumar

Keywords

Typhoid ileal perforation, surgical site infections, antibiotic prophylaxis, Ceftriaxone, Metronidazole, Piperacillin-Tazobactam, gastrointestinal surgery

Abstract

Background: Typhoid ileal perforation is a severe complication requiring prompt surgical intervention, often accompanied by the risk of postoperative surgical site infections (SSIs). Antibiotic prophylaxis is critical in preventing SSIs, but the optimal regimen for such surgeries remains debated.


Objective: This study aimed to evaluate the comparative effectiveness of three antibiotic prophylaxis protocols—Ceftriaxone (Protocol A), Ceftriaxone + Metronidazole (Protocol B), and Piperacillin-Tazobactam (Protocol C)—in reducing the incidence of SSIs following typhoid ileal perforation surgeries.


Materials and Methods: A cross-sectional study was conducted over six months at the Department of General Surgery, People’s University of Medical & Health Sciences, Shaheed Benazirabad, involving 180 patients aged 18 years and older. Patients with known allergies to the antibiotics, chronic infections, or prior abdominal surgeries were excluded. Data were collected through structured questionnaires, capturing demographic information, clinical parameters, antibiotic protocols used, and postoperative outcomes. The incidence of SSIs served as the primary outcome measure. Data were analyzed using Microsoft Excel 2016 and SPSS v21.0, with chi-square tests and logistic regression used to assess statistical significance (p < 0.05).


Results: The study included 120 males (66.7%) and 60 females (33.3%). Protocol B (Ceftriaxone + Metronidazole) demonstrated the lowest SSI rate (16.7%), followed by Protocol C (Piperacillin-Tazobactam) with 16.7%. Protocol A (Ceftriaxone) had the highest SSI rate (33.3%), with a statistically significant association (p = 0.04) compared to Protocol B. No significant differences were found between Protocols B and C. Logistic regression revealed that patients receiving Protocol A were 2.5 times more likely to develop SSIs than those on Protocol B (OR = 2.5, p = 0.03). Age, gender, and comorbidities showed no significant association with SSIs (p > 0.05).


Conclusion: This study highlights the superior effectiveness of combination therapy with Ceftriaxone and Metronidazole (Protocol B) in preventing SSIs compared to Ceftriaxone monotherapy. While Piperacillin-Tazobactam (Protocol C) performed comparably to Protocol B, broader-spectrum antibiotics may not offer a distinct advantage in regions with low resistance.

Abstract 62 | PDF Downloads 23

References

1. Nasir AA, Rothstein DH, Cox S, Ameh EA. Surgical Site Infection. In: Pediatric Surgery. Cham: Springer International Publishing; 2020. p. 165–72.
2. Mejri A, Yaacoubi J, Mseddi MA, Omry A. Gastrointestinal perforations by ingested foreign bodies: A preoperative diagnostic flowchart-based experience. A case series report. Int J Surg Case Rep. 2022 Jun;95:107216.
3. Thabit AK, Fairaq EM, Almutairi FS. Appropriateness of choice and duration of surgical antibiotic prophylaxis and the incidence of surgical site infections: A prospective study. J Taibah Univ Med Sci. 2023 Feb;18(1):26–31.
4. Barac R, Als D, Radhakrishnan A, Gaffey MF, Bhutta ZA, Barwick M. Implementation of Interventions for the Control of Typhoid Fever in Low- and Middle-Income Countries. Am J Trop Med Hyg. 2018 Sep 6;99(3_Suppl):79–88.
5. Anyomih TTK, Drake TM, Glasbey J, Fitzgerald JE, Ots R, Harrison EM, et al. Management and Outcomes Following Surgery for Gastrointestinal Typhoid: An International, Prospective, Multicentre Cohort Study. World J Surg. 2018 Oct 3;42(10):3179–88.
6. Rajan DS, Harikumar A, . S. A clinicopathological study of thyroid swellings in a tertiary centre. J Case Reports Sci Images. 2021 Jan 1;3(1):01–3.
7. Kothari RD, Barde A, Bhide H, Deshpande T, Narkar NS, Tilak A V. Use of Cephalosporin Type Antimicrobials in Infection Wards in Tertiary Hospital in West India. J Pharm Res Int. 2021 Sep 15;510–7.
8. Grema B, Aliyu I, Michael G, Musa A, Fikin A, Abubakar B, et al. Typhoid ileal perforation in a semi-urban tertiary health institution in north-eastern Nigeria. South African Fam Pract. 2018 Sep 3;60(5):168–73.
9. Uecker H, Bonhoeffer S. Antibiotic treatment protocols revisited: the challenges of a conclusive assessment by mathematical modelling. J R Soc Interface. 2021 Aug 25;18(181).
10. Hassan RSEE, Osman SOS, Aabdeen MAS, Mohamed WEA, Hassan RSEE, Mohamed SOO. Incidence and root causes of surgical site infections after gastrointestinal surgery at a public teaching hospital in Sudan. Patient Saf Surg. 2020 Dec 7;14(1):45.
11. Kannan A, Ravichandran M, Sundaramurthi S, Win M, Tara A, Ruo SW, et al. Is Single-Dose Antimicrobial Prophylaxis Sufficient to Control Infections in Gastrointestinal Oncological Surgeries? Cureus. 2021 Aug 6;
12. Vasu S, Sagar K. A randomised controlled trial comparing the efficacy of single dose prophylactic ceftriaxone versus post-operative ciprofloxacin and metronidazole combination in reducing post-operative wound infection after clean surgeries. Int Surg J. 2018 Nov 28;5(12):3864.
13. D’Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gönen M, Thompson VM, et al. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy. JAMA. 2023 May 9;329(18):1579.
14. Vu CH, Venugopalan V, Santevecchi BA, Voils SA, Ramphal R, Cherabuddi K, et al. Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (REDUCE-BSI). Antimicrob Steward Healthc Epidemiol. 2022 Mar 11;2(1):e39.
15. Ruiz de Gopegui Miguelena P, Martínez Lamazares MT, Miguelena Hycka J, Claraco Vega LM, Gurpegui Puente M. Influence of frailty in the outcome of surgical patients over 70 years old with admission criteria in ICU. Cirugía Española (English Ed. 2021 Jan;99(1):41–8.
16. Zwicky SN, Gloor S, Tschan F, Candinas D, Demartines N, Weber M, et al. Impact of gender on surgical site infections in abdominal surgery: A multi-center study. Br J Surg. 2022 May 31;109(Supplement_3).
17. Li H, Wu X, Bai Y, Wei W, Li G, Fu M, et al. Physical activity attenuates the associations of systemic immune-inflammation index with total and cause-specific mortality among middle-aged and older populations. Sci Rep. 2021 Jun 15;11(1):12532.
18. Soleimanpour S, Hasanian SM, Avan A, Yaghoubi A, Khazaei M. Bacteriotherapy in gastrointestinal cancer. Life Sci. 2020 Aug;254:117754.
19. Tarazi M, Jamel S, Mullish BH, Markar SR, Hanna GB. Impact of gastrointestinal surgery upon the gut microbiome: A systematic review. Surgery. 2022 May;171(5):1331–40.

Most read articles by the same author(s)